This article is available online at http://www.jlr.org stress and infl ammatory processes ( 2-4 ). In addition to these properties, it has been reported that quercetin is able to reduce plasma cholesterol levels in hyperlipidemia animals ( 5-7 ). Hypercholesterolemia is one of the major risk factors for the development and progression of atherosclerosis ( 8, 9 ) . It seems that quercetin may play an essential role in the prevention of atherosclerosis. Hypercholesterolemia promotes the entry and retention of cholesterol-rich low-density lipoprotein (LDL) within the arterial wall. The accumulated oxidized LDL (oxLDL) in the subendothelial space of vessels is taken up by macrophages through scavenger receptors. However, unlimited uptake of oxLDL results in foam cell formation, a pathological hallmark of early atherosclerosis. Cholesterol effl ux from macrophages is a key mechanism to prevent the development of atherosclerosis ( 10-13 ). Despite the importance of cholesterol accumulation in the development of atherosclerosis, little is known about the biological effects and molecular mechanisms of quercetin on cholesterol transportation in macrophages.
stress and infl ammatory processes (2) (3) (4) . In addition to these properties, it has been reported that quercetin is able to reduce plasma cholesterol levels in hyperlipidemia animals (5) (6) (7) . Hypercholesterolemia is one of the major risk factors for the development and progression of atherosclerosis ( 8, 9 ) . It seems that quercetin may play an essential role in the prevention of atherosclerosis. Hypercholesterolemia promotes the entry and retention of cholesterol-rich low-density lipoprotein (LDL) within the arterial wall. The accumulated oxidized LDL (oxLDL) in the subendothelial space of vessels is taken up by macrophages through scavenger receptors. However, unlimited uptake of oxLDL results in foam cell formation, a pathological hallmark of early atherosclerosis. Cholesterol effl ux from macrophages is a key mechanism to prevent the development of atherosclerosis (10) (11) (12) (13) . Despite the importance of cholesterol accumulation in the development of atherosclerosis, little is known about the biological effects and molecular mechanisms of quercetin on cholesterol transportation in macrophages.
ATP-binding cassette transporter A1 (ABCA1), a member of the ATP-binding cassette transporter family, is involved in the control of apolipoprotein AI (apoAI)-mediated cholesterol effl ux from macrophages ( 14, 15 ) . A previous study has shown that overexpression of ABCA1 in LDL receptor-defi cient mice reduces lipid accumulation in the arterial wall ( 16 ) . Thus, induction of ABCA1 expression is considered an attractive approach to preventing excessive cholesterol accumulation and atherosclerosis. The expression of ABCA1 is transcriptionally regulated by nuclear transcription factor liver X receptor (LXR) and retinoid X Abstract ATP-binding cassette transporter A1 (ABCA1) plays a crucial role in exporting cholesterol from macrophages, a function relevant to its involvement in the prevention of atherosclerosis. Quercetin, one of fl avonoids, has been described to reduce atherosclerotic lesion formation. This study is aimed to investigate the effect of quercetin on regulation of ABCA1 expression and to explore its underlying mechanisms in macrophages. The results show that quercetin markedly enhanced cholesterol effl ux from macrophages in a concentration-dependent manner, which was associated with an increase in ABCA1 mRNA and protein expression. Remarkably, quercetin is able to stimulate the phosphorylation of p38 by up to 234-fold at 6 h via an activation of the transforming growth factor ␤ -activated kinase 1 (TAK1) and mitogen-activated kinase kinase 3/6 (MKK3/6). Inhibition of p38 with a pharmacological inhibitor or small hairpin RNA (shRNA) suppressed the stimulatory effects of quercetin on ABCA1 expression and cholesterol effl ux. Moreover, knockdown of p38 reduced quercetin-enhanced ABCA1 promoter activity and the binding of specifi city protein 1 (Sp1) and liver X receptor ␣ (LXR ␣ ) to the ABCA1 promoter using chromatin immunoprecipitation assays. These fi ndings provide evidence that p38 signaling is essential for the regulation of quercetin-induced ABCA1 expression and cholesterol efflux in macrophages. -Chang, Y-C., T-S. Lee, and A-N. Chiang. Quercetin enhances ABCA1 expression and cholesterol effl ux through a p38-dependent pathway in macrophages. J. Lipid Res. 2012. 53: 1840-1850.
(DMEM; Hyclone Laboratories, Logan, UT) supplemented with 10% fetal bovine serum (FBS; PAA Laboratories, Linz, Austria), 100 units/ml penicillin, and 100 g/ml streptomycin. All cell experiments were performed in a humidifi ed atmosphere at 37°C with 5% CO 2 . Bone marrow-derived macrophages (BMDM) were isolated and cultured from 6-to 12-week-old C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) as previously described ( 26 ) . The animal experiments conformed to the PHS policy and approved by the Animal Care and Utilization committee of National Yang-Ming University. Briefl y, bone marrow cells isolated from femurs were cultured for 7 days in Petri dishes with DMEM containing 20% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, and 50 ng/ml macrophage colony-stimulating factor (M-CSF; R and D Systems, Minneapolis, MN) at 37°C in a 5% CO 2 atmosphere. On day 7, adherent BMDM were obtained and cultured in DMEM supplemented with 10% FBS, 100 units/ml penicillin, 100 g/ml streptomycin, and 50 ng/ml M-CSF. Quercetin dihydrate (Sigma-Aldrich, St. Louis, MO) was fi rst dissolved in dimethyl sulfoxide (DMSO) and diluted by medium containing 2% FBS to achieve the fi nal concentration. Medium containing 0.05% DMSO was used as the control group.
Cholesterol effl ux
RAW264.7 macrophages or BMDM plated on 24-well plates were radiolabeled with 0.5 Ci/ml [1,2- 3 H]cholesterol (PerkinElmer, Boston, MA) in DMEM containing 0.2% BSA (BSA; Sigma-Aldrich) for 24 h. To deliver macrophages with more cholesterol, cells were also treated with cholesterol (Wako Pure Chemical Industries, Osaka, Japan) dissolved in ethanol and diluted into serum-free medium at the appropriate concentrations. RAW264.7 macrophages were incubated in 0.2% BSA-containing DMEM with 10 g/ml of acetylated low-density lipoprotein (AcLDL; Molecular Probes, Eugene, OR) or 30 g/ml of cholesterol in the presence of 0.5 Ci/ml [1,2- 3 H]cholesterol for 24 h. Subsequently, cells were washed and incubated with quercetin in indicated concentrations for another 24 h. To perform apoAI-mediated cholesterol effl ux, the medium was replaced with fresh medium containing 0.2% BSA with or without 10 g/ml lipid-free human apoAI (Sigma-Aldrich) for 24 h. The effl ux medium was then collected and centrifuged to remove cell debris. Cells were lysed in 0.1 N NaOH, and radioactivities of the medium and the cell lysate were measured by liquid scintillation counting. Cholesterol effl ux was expressed as the percentage of counts in the medium relative to the total counts (medium and cells). ApoAI-specifi c cholesterol effl ux was obtained by subtracting the nonspecifi c effl ux that occurred in apoAI-free medium. For TAK1 inhibition study, RAW264.7 macrophages or BMDM were pretreated with 5 M 5Z-7-Oxozeaenol for 1 h and then treated with 100 M quercetin for 24 h.
RNA extraction and quantitative real-time PCR analysis
Total cellular RNA was extracted by TRI Reagent (SigmaAldrich) following the manufacturer's protocol. Reverse transcription was carried out with 2 g total RNA using moloney murine leukemia virus reverse transcriptase (MMLV; Invitrogen, Carlsbad, CA). Quantitative real-time PCR was assessed using SYBR Green PCR Master Mix (Finnzymes, Espoo, Finland) on a Roche LightCycler system (Roche Diagnostics, Mannheim, Germany). The primer sequences were as follows: ABCA1 (forward 5 ′ -GG-TTTGGAGATGGTTATACAATAGTTGT-3 ′ and reverse 5 ′ -CCC GG AA-ACGCAAGTCC-3 ′ ) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, forward 5 ′ -GTATGACTCCACTCAC GG CAAA-3 ′ and reverse 5 ′ -GGTCTCGCTCCTGGAAGATG-3 ′ ). GAPDH was used for the internal normalization.
receptor (RXR) ( 17, 18 ) . When LXR is activated by its natural ligand, oxysterols, it forms heterodimers with RXR and binds to the ABCA1 promoter to activate gene expression. Thymiakou et al. found that transcription factor specifi city protein 1 (Sp1) regulated ABCA1 expression via physical interaction with the LXR/RXR heterodimer in human hepatoma cells treated with oxysterols and retinoids ( 19 ) . In addition, Sp1 has been reported to be involved in quercetin-regulated gene expression ( 20, 21 ) ; however, the involvement of Sp1 and LXR in quercetininduced ABCA1 transcription is still to be elucidated.
In addition to transcription factor-mediated ABCA1 gene regulation, mitogen-activated protein kinase (MAPK) signaling cascades have been reported to modulate ABCA1 expression (22) (23) (24) . The MAPK family comprises extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinase 1/2 (JNK1/2), and p38 ( 25 ) . Inhibition of ERK activation leads to increase ABCA1 mRNA and protein stabilities, which results in the activation of ABCA1 expression ( 22 ) . Activation of p38 has been reported to modulate ABCA1 expression in vascular smooth muscle cells and macrophages ( 23, 24 ) . Nevertheless, little is known about the contribution of the MAPK signaling cascades to quercetin-mediated ABCA1 gene regulation.
The aim of the study was to investigate whether quercetin stimulates cholesterol effl ux via the induction of ABCA1 expression in macrophages, as well as to explore its molecular mechanisms. Our results show that quercetin markedly increases apoAI-mediated cholesterol effl ux via elevation of ABCA1 gene expression. Furthermore, quercetin activates the p38 signaling cascade via stimulating phosphorylation of transforming growth factor ␤ -activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase 3/6 (MKK3/6), the upstream kinases of p38. Moreover, quercetin enhances p38-mediated binding of Sp1 and LXR ␣ to the corresponding binding sites located within Ϫ 250/ Ϫ 1 region of the ABCA1 promoter. Our results provide a new insight into the mechanisms underlying the biological effect of quercetin on cholesterol effl ux.
MATERIALS AND METHODS

Materials
SB203580 (p38 inhibitor) and 5Z-7-Oxozeaenol (TAK1 inhibitor) were obtained from Calbiochem (San Diego, CA). Antibodies recognizing ABCA1, ␣ -tubulin, LXR ␣ , B23, and rabbit control IgG were purchased from Abcam (Cambridge, UK). Antibodies against phospho-p38, phospho-ERK1/2, phospho-JNK1/2, phospho-MKK3/6, phospho-TAK1, total p38, total ERK1/2, total JNK1/2, and total MKK3 were obtained from Cell Signaling Technology (Beverly, MA). Total TAK1 antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Sp1 antibody was obtained from Millipore (Temecula, CA).
Cell culture
Murine macrophage cell line RAW264.7 was originally obtained from the American Type Culture Collection (Manassas, VA). Cells were grown in Dulbecco's modifi ed Eagle's medium fresh DMEM containing 10% FBS and incubated for further 18 h at 37°C. Cells were then treated with 100 M quercetin for 24 h and lysed with lysis buffer (70 mM K 2 HPO 4 , 2.1 mM MgCl 2 , 55 mM Tris-HCl, pH 7.8, 0.7 mM dithiothreitol, and 1% Triton X-100). Cell lysates were harvested by centrifugation. Luciferase activity was quantifi ed with a VICTOR 2 Multilabel Reader (PerkinElmer). ␤ -galactosidase activity was measured by incubating cell extracts with o -nitrophenyl-␤ -D-galactopyranoside (SigmaAldrich). Relative luciferase activity was presented as fi refl y luciferase values normalized to ␤ -galactosidase activity.
Nuclear protein extraction
Cells were lysed by hypotonic lysis buffer [20 mM HEPES, pH 7.4, 10 mM KCl, 1 mM MgCl 2 , 0.5% NP-40, 0.5 mM dithiothreitol, and complete protease inhibitor cocktail (Roche Diagnostics)]. Nuclei were pelleted by centrifugation and lysed by high salt nuclear extraction buffer [20 mM HEPES, pH 7.4, 10 mM KCl, 1 mM MgCl 2 , 400 mM NaCl, 0.5 mM dithiothreitol, and complete protease inhibitor cocktail (Roche Diagnostics)]. The nuclear proteins were harvested after centrifugation.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) experiments were performed according to the manufacturer's instructions (Cell Signaling Technology, Beverly, MA) with some modifi cations. RAW264.7 macrophages were treated with or without 100 M quercetin for 3 h, harvested, and crosslinked with 1% formaldehyde at 37°C for 10 min. Crosslinking was stopped by adding
Western blot analysis
Cells were lysed with lysis buffer [20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 50 mM dithiothreitol, complete protease inhibitor cocktail (Roche Diagnostics) and phosphatase inhibitor cocktail I and II (SigmaAldrich)]. The cell lysates were centrifuged and the supernatants were collected. The protein concentration was assayed using Bradford reagent (Bio-Rad, Hercules, CA) with BSA as the standard. Equal amounts of protein were analyzed by SDSpolyacrylamide gel, and transferred to nitrocellulose membranes (Pall, Glen Cove, NY). The immunoblots were blocked with 5% nonfat milk in PBST (5.8 mM Na 2 HPO 4 ·7H 2 O, 130 mM NaCl and 0.05% Tween-20) for 1 h at room temperature, and then incubated with fi rst antibodies overnight at 4°C. After PBST wash, the blots were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma-Aldrich), and the target protein bands were visualized by using enhanced chemiluminescence system (ECL; PerkinElmer). The blots were then stripped for further probing with ␣ -tubulin or B23 antibody as internal controls for the total cellular or nuclear proteins, respectively. Relative intensities of protein bands were quantifi ed by densitometry using Image Quant software (Molecular Dynamics, Sunnyvale, CA).
Lentivirus-mediated RNA interference
Knockdown of p38 expression was performed by the lentiviruspackaged small hairpin RNA (shRNA) approach. Two different clones expressing p38-targeting shRNAs were obtained from the National RNAi Core Facility of Academia Sinica (Taiwan). The targeting sequences of these two clones were as follows: p38 shR-NA-1 (5 ′ -CCTCTTGTTGAAAGATTCCTT-3 ′ ) and p38 shRNA-2 (5 ′ -GCTGAATTGGATGCACTATAA-3 ′ ). Luciferase shRNA was used as a control shRNA. Briefl y, lentiviral-containing shRNAs at an MOI of 3 were used to infect RAW264.7 macrophages in the presence of 8 g/ml polybrene (Sigma-Aldrich). After 24 h, the infected cells were selected with 2 g/ml puromycin (SigmaAldrich) for two weeks to generate stable-knockdown cells. The knockdown effi ciency of p38 was examined by Western blot analysis using anti-total p38 antibody.
Construction of ABCA1 promoter-driven luciferase reporter plasmids
Various lengths of the mouse ABCA1 promoter sequences were amplifi ed by PCR using the primers as indicated ( Table 1 ) . Each PCR fragment was subsequently cloned into the Xho I/ Hind III restriction sites of the luciferase reporter plasmid pGL3-basic vector (Promega, Madison, WI). To introduce sitespecific mutations in putative transcription factor binding sites within Ϫ 250/ Ϫ 1 region of the ABCA1 promoter, sitedirected mutagenesis was performed using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The DNA sequences of the constructs were verifi ed by automated DNA sequencing. The mouse p38 expression plasmid (pRcCMV-p38) was a gift from Professor Fung-Fang Wang's lab (National Yang-Ming University, Taipei, Taiwan).
Transient transfection and luciferase assay
Transient transfection was performed using Lipofectamine LTX and PLUS reagents (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cells were cotransfected with 1 g of ABCA1 promoter-driven luciferase reporter plasmid and 0.5 g of pCMV-␤ -galactosidase expression plasmid in serum-free DMEM. After 6 h of transfection, the medium was replaced with 
Restriction enzyme cutting sites are underlined. Mutations are indicated by lowercase letters.
RESULTS
Quercetin enhances cholesterol effl ux and ABCA1 expression in macrophages
To determine whether quercetin may infl uence cholesterol homeostasis, we fi rst investigated the role of quercetin in the control of apoAI-mediated cholesterol effl ux from macrophages. The results in Fig. 1A showed that quercetin concentration-dependently enhanced apoAImediated cholesterol effl ux from RAW264.7 macrophages and primary macrophages, BMDM. We also treated RAW264.7 macrophages with AcLDL or cholesterol to examine the effect of quercetin on cholesterol effl ux from the cholesterol-loaded macrophages. As shown in Fig. 1B , quercetin increased apoAI-mediated cholesterol effl ux from AcLDL-or cholesterol-loaded macrophages in a dose-dependent manner. As the importance of ABCA1 in apoAI-mediated cholesterol effl ux has been established ( 14, 15 ), we next examined the effect of quercetin on the mRNA level of ABCA1 by quantitative real-time PCR. The results revealed that quercetin also upregulated the ABCA1 mRNA level in a dose-dependent manner up to 6-fold at 100 M quercetin treatment ( Fig. 1C ) . We then investigated whether the elevated ABCA1 mRNA level resulted in an increased expression of ABCA1 protein. As shown in Fig. 1D , ABCA1 protein level was increased in a concentration-dependent manner up to 8-fold when cells were subjected to 100 M quercetin treatment. These results suggest that quercetin-induced ABCA1 is a facilitating factor in the stimulation of cholesterol effl ux from macrophages. . Chromatin was digested into fragments of 150-900 bp by MNase (New England Biolabs, Beverly, MA), and this was followed by sonication to disrupt nuclear membrane. For immunoprecipitation, 15-25 g of chromatin was incubated with 1 g of antibodies against Sp1 or LXR ␣ . Nonimmune IgG was used as a negative control. Antibody-protein-DNA complexes were pulled down with 50% protein A agarose beads/salmon sperm DNA slurry (Millipore, Temecula, CA). Precipitated chromatin complexes were eluted with elution buffer (1% SDS and 0.1 M NaHCO 3 ). Crosslinking was reversed with 250 mM NaCl and proteinase K overnight at 65°C. DNA was purifi ed by phenol/chloroform extraction and isopropanol precipitation in the presence of glycogen. The fragments of the ABCA1 promoter containing the predicted Sp1 and LXR ␣ binding sites were detected by PCR using the primers as follows: forward 5 ′ -GGCGGGCCAT G TCTCCACG-3 ′ and reverse 5 ′ -GCTCGCTCGCCCTCGGAATT-3 ′ . The PCR products were separated on a 2% agarose gel and visualized by ethidium bromide staining.
Statistical analysis
Data are expressed as mean ± SEM of at least three independent experiments. Statistical analysis was performed using Student t -test or one-way ANOVA with the Tukey's method as a posthoc test. A value of P < 0.05 was considered statistically significant. 3 H]cholesterol-labeled macrophages with or without 10 g/ml apoAI for 24 h. Cholesterol effl ux was expressed as the percentage of radioactivity in the medium relative to the total radioactivity (medium and cells). B: RAW264.7 macrophages were loaded with 10 g/ml of acetylated low-density lipoprotein (AcLDL) or 30 g/ml cholesterol in the presence of [ 3 H]cholesterol for 24 h. Cholesterol effl ux was measured as described in Materials and Methods. C: After cells were treated with quercetin for 18 h, mRNA levels of ABCA1 were detected by quantitative real-time PCR and normalized to GAPDH. D: Cells were treated with quercetin for 24 h, and then total cell extracts were harvested. ABCA1 protein expressions were measured by Western blot analysis and ␣ -tubulin was utilized as a loading control. The normalized level of mRNA or protein from cells without quercetin treatment was set as 1. Results are expressed as mean ± SEM (n = 3-5). * P < 0.05, ** P < 0.01 versus control group.
Quercetin induces phosphorylation of p38, TAK1, and MKK3/6
To investigate the mechanisms underlying the regulation of ABCA1 expression by quercetin, we assessed the effect of quercetin on the phosphorylation of p38, ERK, and JNK. Quercetin time-dependently induced the phosphorylation of p38 by 168-fold to 234-fold at 2 to 6 h ( Fig. 2A ) . However, there were no significant differences in the levels of phosphorylated ERK and JNK among the groups at various times compared with the 0 h group. As TAK1 and MKK3/6 are upstream kinases of p38 ( 27 ) , we next examined the effect of quercetin on the activation of TAK1 and MKK3/6. The levels of phosphorylated TAK1 and MKK3/6 were significantly increased after quercetin treatment for 0.5 to 6 h ( Fig. 2B ) . Therefore, we next assessed the effect of 5Z-7-Oxozeazenol (5Z-7-Oxo), a specific TAK1 inhibitor, on the quercetin-induced phosphorylation of p38, TAK1, and MKK3/6. As shown in Fig. 2B , the phosphorylation levels of p38, TAK1, and MKK3/6 were markedly suppressed by 5Z-7-Oxo. Moreover, we investigated the effect of 5Z-7-Oxo on quercetin-induced cholesterol efflux from RAW264.7 macrophages or BMDM. 5Z-7-Oxo significantly reversed the induction of cholesterol efflux by quercetin ( Fig. 2C, D ) . These results indicate that TAK1-MKK3/6-p38 signaling cascade is essential for the regulation of quercetin-stimulated cholesterol efflux from macrophages.
p38 activation is crucial for the regulation of quercetin-induced ABCA1 expression
To understand the mechanisms of quercetin-induced regulation of ABCA1 expression, we addressed whether the p38 signaling pathway was necessary for ABCA1 induction. RAW264.7 macrophages were pretreated with SB203580, a pharmacological inhibitor of p38, followed by treatment with quercetin. Quercetin-induced ABCA1 mRNA and protein expression were remarkably atte n uated in cells treated with SB203580 ( Fig. 3A , B) . Moreover, a signifi cant reduction in p38 was observed when p38 shRNA-1-and p38 shRNA-2-expressing cells (RAW264.7 macrophages were infected with lentivirus containing p38-targeting shRNAs) were examined ( Fig. 3C ) . Luciferase shRNA was used as a control shRNA. Importantly, both mRNA and protein levels of ABCA1 induced by quercetin were signifi cantly suppressed in p38 shRNA-expressing cells ( Fig. 3D, E ) . In line with the inhibitory effect of p38 knockdown on ABCA1 expression, quercetin-induced cholesterol effl ux was also suppressed in p38 shRNAexpressing cells ( Fig. 3F ) . Together, these results support the critical role of p38 in the induction of ABCA1 expression by quercetin and the subsequent changes in cholesterol effl ux in macrophages. . 3 . p38 is involved in the quercetin-induced ABCA1 expression and cholesterol effl ux. RAW264.7 macrophages were pretreated with 20 M SB203580 (p38 inhibitor), and then treated with 100 M quercetin. A: The ABCA1 mRNA levels were measured by quantitative real-time PCR and normalized to GAPDH. B: The ABCA1 protein levels were detected by Western blot analysis and ␣ -tubulin was utilized as a loading control. The normalized level of mRNA or protein from cells without quercetin treatment was set as 1. RAW264.7 macrophages were infected with lentivirus expressing p38 shRNA-1 or p38 shRNA-2 to confi rm the effects of p38 on quercetin-induced ABCA1 expression and cholesterol effl ux. Luciferase shRNA (Luc. shRNA) was used as a control shRNA. C: The knockdown effi ciency of p38 was checked by Western blot analysis. D, E: The effect of p38 knockdown on quercetin-induced ABCA1 mRNA (D) and protein (E) expression was examined by quantitative real-time PCR and Western blot analysis, respectively. The normalized level of mRNA or protein from parental cells without quercetin treatment was given as 1. F: Cholesterol effl ux from p38 knockdown cells to media was measured in the presence of 10 g/ml apoAI. Cholesterol effl ux was expressed as the percentage of radioactivity in the medium relative to the total radioactivity (medium and cells). Values are mean ± SEM (n = 3-6). * P < 0.05, ** P < 0.01, # P < 0.05, ## P < 0.01. Fig. 4 , the luciferase activity of the constructs from Ϫ 1550 to Ϫ 250 sites showed signifi cantly higher luciferase activity (WT-250, 6.1 ± 0.5-fold; WT-400, 6.6 ± 0.6-fold; WT-700, 6.5 ± 0.6-fold; WT-1100, 5.9 ± 0.4-fold; and WT-1550, 4.8 ± 0.2-fold) compared with the promoter activity in the transfected cells without treatment of quercetin (WT-250, 2.3 ± 0.2-fold; WT-400, 2.5 ± 0.2-fold; WT-700, 2.8 ± 0.2-fold; WT-1100, 2.4 ± 0.1-fold; and WT-1550, 1.9 ± 0.2-fold). These observations imply that the main quercetin-responsive region required for ABCA1 promoter activity is located in the region between Ϫ 250 and Ϫ 1 bp.
Identifi cation of the quercetin-responsive region within the ABCA1 promoter
The results in Fig. 1B implies that quercetin may regulate ABCA1 expression at the transcription level. To defi ne the quercetin-responsive region within the ABCA1 promoter, we generated fi ve 5 ′ -serial deletion constructs, wild-type (WT)-1550, WT-1100, WT-700, WT-400, and WT-250, that contained the ABCA1 promoter region between Ϫ 1550 and Ϫ 1 bp. All fragments of the ABCA1 promoter constructs were analyzed for luciferase activity in RAW264.7 macrophages treated in the absence or presence of 100 M quercetin. As shown in
The binding of Sp1 and LXR ␣ to the ABCA1 promoter is mediated through p38 activation
We also investigated whether the stimulatory effect of quercetin on ABCA1 gene expression was mediated through p38 signaling in p38 shRNA-expressing cells. As shown in Fig. 6A , attenuation of quercetin-induced ABCA1 promoter activity was observed in the p38 knockdown cells. In addition, we conducted rescue experiments using macrophages that overexpressed p38. The results showed that overexpression of p38 rescued the promoter activity when compared with the p38 knockdown cells ( Fig. 6A ) . Together, these fi ndings suggest that p38 plays an essential role in the quercetin-induced ABCA1 promoter activity. Moreover, the binding of Sp1 and LXR ␣ to the ABCA1 promoter induced by quercetin was greatly reduced in p38 knock down cells using ChIP assays ( Fig. 6B ). These observations confi rm that p38 is required for the binding of Sp1 and LXR ␣ to the ABCA1 promoter, suggesting that p38-mediated Sp1 and LXR ␣ activation is involved in the regulation of quercetininduced ABCA1 gene expression.
DISCUSSION
In this study, we investigated the molecular mechanisms underlying quercetin-regulated ABCA1 expression and cholesterol effl ux in macrophages. As illustrated in Fig. 7 , our results show that quercetin induces apoAI-mediated cholesterol efflux through activation of ABCA1 mRNA and protein expression in RAW264.7 macrophages. It is clear that quercetin-induced ABCA1 expression and cholesterol effl ux are mediated by activating the TAK1-MKK3/6-p38 signaling cascade. Moreover, activated p38 signaling increases the binding of Sp1 and LXR ␣ to their corresponding cis -elements within the Ϫ 250/ Ϫ 1 region of the ABCA1 promoter, which in turn increases ABCA1 gene expression in macrophages.
The Sp1 and LXR binding sites are critical for the regulation of quercetin-induced ABCA1 promoter activity
The potential binding sites for Sp1, E-box, AP1, and LXR/RXR within the Ϫ 250/ Ϫ 1 region of the ABCA1 promoter were predicted by using the TRANSFAC program ( 28 ) ( Fig. 4 ) . To address the importance of these transcription factor binding sites in quercetin-induced ABCA1 promoter activities, we generated several mutated constructs (mSp1a, mE-box, mAP1, mSp1b, and mlXR) by site-directed mutagenesis as shown in Fig. 5A . The results showed that mutagenesis of the Sp1b or LXR sites attenuated quercetin-induced ABCA1 promoter activity compared with the level of WT-250 promoter. Moreover, a construct containing double mutations of Sp1b and LXR sites (mSp1b/mLXR) was generated to validate whether these two sites were essential for the regulation of quercetin-induced ABCA1 promoter activity. It is clear that quercetin-induced promoter activity of mSp1b/mLXR showed a more signifi cant decrease compared with that of Sp1b or LXR mutation alone ( Fig. 5A ) . We thus assume that Sp1b and LXR sites are both required for the regulation of ABCA1 gene expression in cells under quercetin treatment.
As depicted in Fig. 5B , the nuclear levels of Sp1 and LXR were increased in cells treated with quercetin, suggesting that both Sp1 and LXR may be involved in the regulation of quercetin-induced ABCA1 gene expression. The binding properties of Sp1 and LXR ␣ to the ABCA1 promoter were also examined by ChIP assays. Antibodies against Sp1 or LXR ␣ were used to immunoprecipitate the protein-chromatin complex. It was found that the interaction of Sp1 and LXR ␣ with the Ϫ 250/ Ϫ 1 region of ABCA1 promoter was signifi cantly increased ( Fig. 5C ) . These results are consistent with those of the mutagenesis study, indicating that quercetin stimulates ABCA1 promoter activity via the binding of Sp1 and LXR ␣ to the ABCA1 promoter region between Ϫ 250 and Ϫ 1 bp. These observations confi rm the essential role of Sp1 and LXR ␣ activation in quercetin-induced ABCA1 gene expression. Fig. 4 . Characterization of quercetin-responsive domains in the ABCA1 promoter. Schematic diagram of putative binding sites for transcription factors and serial deletion constructs of ABCA1 promoter are shown. RAW264.7 macrophages were transiently cotransfected with 1 g of indicated constructs and 0.5 g of pCMV ␤ -galactosidase expression plasmid, and then treated with 100 M quercetin (Q100) for 24 h. Luciferase activity was normalized with ␤ -galactosidase activity. Results are shown as fold changes in luciferase activity relative to the untreated pGL3-basic vector group. The level of luciferase activity without quercetin treatment in pGL3-basic vector group was given the value of 1. Bars are mean ± SEM (n = 3). ** P < 0.01 versus quercetin-treated pGL3-basic vector group.
Over the past decade, some in vitro and in vivo studies have shown that quercetin has anti-oxidative and anti-infl ammatory effects ( 2, 3, 29 ) . Other researchers have indicated that quercetin reduces plasma cholesterol levels and atherosclerotic progression in rabbits and hamsters fed with a high-fat diet, which implies that quercetin may also have anti-lipidemia and anti-atherosclerotic properties ( 6, 7 ) . Cholesterol effl ux from cholesterol-loaded For p38 overexpression, p38 knockdown cells were transiently cotransfected with 0.5 g of WT-250 construct, 0.5 g of pRcCMV-p38 plasmid, and 0.5 g of pCMV ␤ -galactosidase plasmid. After transfection, cells were treated with 100 M quercetin (Q100) for 24 h. Luciferase activity was normalized with ␤ -galactosidase activity and expressed as fold changes in luciferase activity compared with respective control groups. The level of luciferase activity without quercetin treatment was given the value of 1. WT-250, Ϫ 250/ Ϫ 1 region of ABCA1 promoter. B: ChIP assays were performed to observe the binding of Sp1 and LXR ␣ to the ABCA1 promoter in p38 knockdown cells as described in Materials and Methods. Nonimmune IgG was used as the negative control. The results of ChIP assays were evaluated by PCR and gel electrophoresis. Values are quantifi ed by densitometer and expressed as ratio relative to inputs. Bars are mean ± SEM (n = 3). ** P < 0.01, # P < 0.05, ## P < 0.01.
Fig. 5.
Sp1 and LXR binding sites are quercetin-responsive elements within the ABCA1 promoter. A: Six mutation constructs of ABCA1 promoter in the potential Sp1a, E-box, AP1, Sp1b, and LXR recognition sites were generated using site-directed mutatgenesis. RAW264.7 macrophages were transiently cotransfected with 1 g of indicated mutant constructs and 0.5 g of pCMV ␤ -galactosidase expression plasmid, and then treated with 100 M quercetin (Q100) for 24 h. Luciferase activity was normalized with ␤ -galactosidase activity and expressed as fold changes in luciferase activity compared with those of the control. The level of luciferase activity without quercetin treatment was given the value of 1. WT-250, Ϫ 250/ Ϫ 1 region of ABCA1 promoter. mSp1b/ mLXR, double mutations at Sp1b and LXR sites. B: Cells were treated with quercetin for 3 h, and nuclear extracts were harvested. The nuclear expression levels of Sp1 and LXR were analyzed by Western blot analysis. The arrow indicates Sp1 band. B23 was used as nuclear loading control, and ␣ -tubulin was used to exclude cytosolic contamination. The level of Sp1 or LXR without quercetin treatment was given the value of 1. C: ChIP assays were performed to observe the binding of Sp1 and LXR ␣ to the ABCA1 promoter in quercetin-treated cells as described in Materials and Methods. Nonimmune IgG was used as the negative control. The results of the ChIP assays were evaluated by PCR and gel electrophoresis. Values are quantifi ed by densitometer and expressed as ratio relative to inputs. Results are mean ± SEM (n = 3-4). ** P < 0.01, # P < 0.05, ## P < 0.01. macrophages leads to an inhibition of atherosclerotic lesion progression ( 16 ) . On the other hand, macrophages lacking ABCA1 are defective in cholesterol efflux in vivo ( 39, 40 ) . Increasing evidence points to induced expression of ABCA1 or promoted function of cholesterol efflux, which is responsible for the reduction of cholesterol accumulation in macrophages treated with dietary flavonoids, such as wogonin and procyanidin ( 41, 42 ) . Our results suggest that the upregulation of ABCA1 expression, both at mRNA and protein levels, by quercetin may be beneficial because it increases the cholesterol efflux from macrophages, thereby resulting in atherosclerotic protection. Moreover, this study is the first to show molecular mechanisms involved in quercetin-mediated ABCA1 gene regulation and cholesterol effl ux. The sequence required for human ABCA1 promoter activity is located in the Ϫ 175/+224 region ( 43 ) . This region includes one LXR binding site (position Ϫ 62) and two Sp1 binding sites (positions Ϫ 90 and Ϫ 156). Additionally, a number of other transcription factor binding sites have been predicted in this region and are conserved in both humans and mice ( 44 ) . Thymiakou et al. reported that both the LXR site and the two Sp1 binding sites were required for the induction of ABCA1 gene transcription in human hepatoma cells treated with oxysterols and retinoids ( 19 ) . We observed that only the proximal Sp1 binding site (Sp1b, position Ϫ 99) was involved in quercetin-stimulated ABCA1 promoter activity. This observation is in agreement with those of Zhao et al. and Chen et al., who found that this Sp1 binding motif (position Ϫ 99) is essential for ABCA1 promoter activity in apoE-or LDL-treated RAW264.7 macrophages ( 45, 46 ) . It has been reported that LXR also participates in the regulation of ABCA1 gene expression ( 17 ) . Similar results were reported by Sevov et al. showing that resveratrol upregulates LXR ␣ expression to induce ABCA1 expression in human macrophages ( 47 ) . Our results indicated that quercetin increased the binding of both LXR ␣ and Sp1 to the ABCA1 promoter in murine cell line RAW264.7 macrophages.
We also found that quercetin potently induced p38 phosphorylation in RAW264.7 macrophages. This result is consistent with the previous fi nding that quercetin induces p38 activation and Sp1 binding to the promoters of tissue-type plasminogen activator ( 21 ) and fi lamin A ( 48 ). These observations suggest that p38 can increase Sp1 promoter binding activity and induce gene transcription. We therefore tested hypothesis that quercetin modulates ABCA1 promoter activity through p38 signaling pathway. This hypothesis was confi rmed by a promoter assay showing that quercetin-induced ABCA1 promoter activity was suppressed in p38 knockdown RAW264.7 macrophages. Kaplan et al. reported that lipopolysaccharide-induced ABCA1 expression was through the p38 signaling pathway in human monocytic leukemia cells ( 24 ) . In contrast, a high concentration of glucose induces p38 activation, but it suppresses ABCA1 expression in vascular smooth muscle cells ( 23 ) . In this study, we found that macrophages is a key atheroprotective mechanism that counteracts cholesterol uptake ( 10, 11 ) . Several lines of evidence indicate that induction of cholesterol effl ux retards the development of atherosclerosis in apolipoprotein E (apoE) knockout mice and LDL receptor knockout mice ( 30, 31 ) . Our results showed that quercetin treatment markedly induced apoAI-mediated cholesterol effl ux in primary macrophages and cholesterol-loaded macrophages, which seems to provide a new explanation for the effect of quercetin on the amelioration of atherosclerotic plaques. In this study, we also explored the molecular mechanisms that affect cholesterol transportation in macrophages. The concentration of quercetin used in our present study was similar to that used in other studies ( 32, 33 ) . A previous study showed that rats, fed 0.2% quercetin diet for 10 days, maintain 100 M concentration of quercetin in the plasma ( 34 ) . Moreover, the concentrations of quercetin in plasma are positively correlated with the intake of quercetin in diet. In the animal study, it seems that the intake of quercetin between 40 and 1,900 mg/kg/day is a safe range for clinical use (35) (36) (37) (38) .
The importance of ABCA1 in apoAI-mediated cholesterol effl ux has been well established ( 14 ) . Transplantation of bone marrow containing ABCA1-overexpressing quercetin induced the TAK1-MKK3/6-p38 signaling cascade and upregulated ABCA1 expression in RAW264.7 macrophages. Moreover, we showed that the quercetin-induced binding of Sp1 to the ABCA1 promoter is suppressed in the p38 knockdown cells. A recent study has shown that a p38 inhibitor, SB202190, inhibits the induction of ABCA1 mRNA expression by LXR ligand in prostate cancer epithelial cells ( 49 ) , implying that p38 could regulate LXRmediated gene transcription. We also found that the quercetin-induced binding of LXR ␣ to the ABCA1 promoter was attenuated in p38 knockdown RAW264.7 macrophages. Collectively, our results indicate that quercetin enhances p38 signaling and subsequently this potentiates the binding of Sp1 and LXR ␣ to the ABCA1 promoter, which in turn increases ABCA1 expression and cholesterol effl ux in macrophages.
In conclusion, this study provides novel insights into the protective effect of quercetin on enhancing cholesterol effl ux via upregulating ABCA1 expression, which is mediated by increasing p38-dependent Sp1 and LXR ␣ binding to the ABCA1 promoter in macrophages. Quercetin may therefore be a promising therapeutic agent for the prevention of atherosclerotic progression.
